Results 31 to 40 of about 228 (152)

PB1958 SUDDEN ONSET HEARING AND VISUAL LOSS: AN UNUSUAL PRESENTATION OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA

HemaSphere, Volume 3, Issue S1, Page 889-890, June 2019., 2019
Background: Hearing loss and blindness are seldom encountered as primary manifestations in patients with chronic myeloid leukemia. Chronic myeloid leukemia (CML) commonly presents with weakness, dysphagia, abdominal distension and pain and rarely constitutional symptoms.
S., S. Tandon, R. Gupta, S. Nityanand
wiley   +1 more source

Mastocitosis sistémica: Revisión sistemática [PDF]

Anales de Medicina Interna, 2008
La mastocitosis es una enfermedad definida por un crecimiento anormal y por la acumulación de mastocitos. En la clasificación de consenso de la OMS del 2001, se distinguió entre procesos bien limitados a piel (mastocitosis cutánea) o bien acumulados a nivel de otros tejidos: médula ósea y/u otros órganos extracutáneos (mastocitosis sistémica) como ...
Molina-Garrido, M.J., Mora, A., Guillén-Ponce, C., Guirado-Risueño, M., Molina, M.J., Molina, M.A., Carrato, A.   +6 more
openaire   +3 more sources

PB1959 THE ROLE OF FLOW CYTOMETRY IN DIFFERENTIAL DIAGNOSIS OF CMML AND REACTIVE MONOCYTOSIS. THE LIPID SIGNAL PATHWAY CHARACTERISTICS IN CLONAL MONOCYTOSIS

HemaSphere, Volume 3, Issue S1, Page 890, June 2019., 2019
Background: Myelodysplastic syndrome (MDS) is a heterogeneous group of diseases characterized by ineffective erythropoiesis and dysplasia. MDS and its subtype CMML is highly associated with chronic inflammatory and autoimmune diseases; however the combination of MDS with other bone marrow neoplasms is not a common entity. Only few cases of MDS combined
A. Sevoyan, A. Sevoyan
wiley   +1 more source

PB1960 CHRONIC MYELOID LEUKEMIA DEVELOPING AFTER SYSTEMIC MASTOCYTOSIS: FAST AND COMPLETE MOLECULAR RESPONSE INDUCED BY IMATINIB.

HemaSphere, Volume 3, Issue S1, Page 890-891, June 2019., 2019
Background: We present here the case of a 52 year old male patient who was diagnosed of D816 V + indolent systemic mastocytosis in 2006. The patient received only symptomatic treatment with fexofenadine, sodium cromoglycate, and ranitidine. In November 7th 2016, mild leukocytosis was detected in one of the screenings.
A. Savchuk, W. Cabrera, E. Sola, J. Cornago, J.F. Del Campo, P. López‐Pereira, A. Orfao, I. Álvarez‐Twose, J.L. Steegmann   +8 more
wiley   +1 more source

PB2227 COMPASSIONATE USE OF ROPEGINTERFERON TO TREAT MYELOPROLIFERATIVE NEOPLASMS IN TAIWAN

HemaSphere, Volume 3, Issue S1, Page 999, June 2019., 2019
Background: There is a high unmet medical need for therapeutic options for patients suffering from myeloproliferative neoplasms (MPN), who have failed or are not eligible to available treatment options. Ropeginterferon‐alfa‐2b (P1101) is a novel, third generation pegylated interferon‐alfa, recently approved by EMA to treat polycythemia vera (PV ...
C.‐C. Chen, M.‐C. Kuo, Y. ‐.‐J. Su, C.‐E. Huang, C.‐C. Hsu, Y.‐Y. Wu, Y.‐J. Chen, L.‐Y. Shih   +7 more
wiley   +1 more source

Urticaria asociada a COVID-19 en pacientes alérgicos. Serie de casos

Revista Alergia México, 2021
Introducción: En diciembre de 2019 fue identificado un nuevo coronavirus como agente causal de la enfermedad por coronavirus del 2019 con un amplio espectro clínico, desde casos asintomáticos hasta críticos y fatales.
Ricardo Cardona, Catalina López
doaj   +1 more source

PB2229 DISEASE CHARACTERISTICS AND RESPONSE TO TREATMENT OF PATIENTS WITH MYELOFIBROSIS:A MULTICENTRE DESCRIPTIVE, RETROSPECTIVE STUDY FROM SRI LANKA

HemaSphere, Volume 3, Issue S1, Page 999, June 2019., 2019
Background: Myelofibrosis (MF)is a BCR/ABL negative, myeloproliferative neoplasm. The manifestations of MF include constitutional symptoms, splenomegaly, anaemia and other cytopenias. Most of the patients are elderly with multiple comorbidities and cannot undergo, allogeneic stem cell transplantation.
D. Moratuwagama, Y. Costa, S. Senanayake, H. Williams, B. Jayaratne B, V. Rathnamalala, N. Ranasinghe, L. Gooneratne, H. Goonesekara, D. Gunewardena, I. Wijesiriwardene, C. Kulathilake C, A. Jayawardene A, J. D. Silva, I. Dharmasena, N. Perera, N. Mendis, P. Vitharana, R. Jayathunga, H. Gunasekara, L. Basnayake, Y. Samaraweera, T. Sooriyakumar, D. Dissanayake, W. Vidyaratne, K. Jayaratne, H. Alwis, R. Wijeratne, A. Attanayake, S. Athawuda, R. Pullaperuma, B. Somarathna, S. Yoganathan, L. Senerath, V. Gunawardena, B. Balasooriya, D. Epa, B. Fernandopulle, C. Moonesinhge   +38 more
wiley   +1 more source

PB2230 SYSTEMIC MASTOCYTOSIS WITH ASSOCIATED HEMATOLOGIC NEOPLASM, EVOLVING TO SIMULTANEOUS CD33 POSITIVE MAST CELL LEUKEMIA AND ACUTE MYELOID LEUKEMIA, TREATED WITH GEMTUZUMAB‐OZOGAMICIN

HemaSphere, Volume 3, Issue S1, Page 999-1000, June 2019., 2019
Background: Mast cell leukemia (MCL) is an extremely rare subtype of systemic mastocytosis (SM), with only 50 cases described so far. It confers an extremely bad prognosis, with an overall survival of few months. Aims: To describe an extremely rare case of MCL and AML treated with Gemtuzumab‐Ozogamicin (GO).
P. López‐Pereira, Á. Figuera, I. Ormazábal, J. Cornago, E. Sola, M. Quesada, A. Savchuk, V. Lizandro, A. de la Fuente, R. Ayala, I. Álvarez‐Twose, J. L. Steegmann   +11 more
wiley   +1 more source

T‐cell immune profile in blood of systemic mastocytosis: Association with disease features

Allergy, Volume 79, Issue 7, Page 1921-1937, July 2024.
Constitutively activated tumour MC in SM patients are associated with a broad activation of the innate immune response and an altered distribution of other adaptive immune cells. The altered circulating T‐ and NK‐cell immune profile in SM varies depending on disease subtype, the pattern of involvement of haematopoiesis by KITD816V, the HαT genotype and
Alba Pérez‐Pons, Cristina Teodosio, María Jara‐Acevedo, Ana Henriques, Paula Navarro‐Navarro, Andrés C. García‐Montero, Iván Álvarez‐Twose, Quentin Lecrevisse, Rafael Fluxa, Laura Sánchez‐Muñoz, Carolina Caldas, Julio Pozo, Silvia Martín, Teresa Contreras Sanfeliciano, Carlos E. Pedreira, Vitor Botafogo, Oscar González‐López, Andrea Mayado, Alberto Orfao   +18 more
wiley   +1 more source

Manejo anestésico de paciente con mastocitosis cutánea [PDF]

Revista Chilena de Anestesia, 2021
Álvaro Pérez Fernández-Escandón
doaj   +1 more source